Found: 12
Select item for more details and to access through your institution.
Immune cell therapies for solid tumors: an overview of challenges and counter measures.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 781, doi. 10.3872/j.issn.1007-385x.2022.09.001
- By:
- Publication type:
- Article
The treatment of multiple myeloma by CAR-T cells: the problems and countermeasures.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 791, doi. 10.3872/j.issn.1007-385x.2022.09.002
- By:
- Publication type:
- Article
The mechanism and relative significance of carboxypeptidase A4 promoting the proliferation, migration, invasion and EMT of non-small cell lung cancer cells.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 797, doi. 10.3872/j.issn.1007-385x.2022.09.003
- By:
- Publication type:
- Article
Ethanol extract from Euphorbia humifusa inhibits the malignant biological behaviors of colorectal cancer SW480 cells by regulating the circRHOT1/miR-29a-3p molecular axis.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 806, doi. 10.3872/j.issn.1007-385x.2022.09.004
- By:
- Publication type:
- Article
Expression and clinical significance of E3 ubiquitin ligase HECW2 in gastric adenocarcinoma tissues.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 813, doi. 10.3872/j.issn.1007-385x.2022.09.005
- By:
- Publication type:
- Article
Expression characteristics and clinical significance of HHLA2 and its receptor TMIGD2 in ovarian cancer tissues.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 822, doi. 10.3872/j.issn.1007-385x.2022.09.006
- By:
- Publication type:
- Article
Efficacy and safety of pembrolizumab plus albumin-bound paclitaxel and nedaplatin as a first-line therapy for advanced esophageal squamous cell carcinoma.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 828, doi. 10.3872/j.issn.1007-385x.2022.09.007
- By:
- Publication type:
- Article
Research progress in CAR-T cell therapies targeting tumor microenvironment in colorectal cancers.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 834, doi. 10.3872/j.issn.1007-385x.2022.09.008
- Publication type:
- Article
Research progress on pathogenesis and immunotargeted therapy of EBV-related tumors.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 840, doi. 10.3872/j.issn.1007-385x.2022.09.009
- Publication type:
- Article
Research progress in the role and mechanism of MMP-9 in the metastasis of non-small cell lung cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 846, doi. 10.3872/j.issn.1007-385x.2022.09.010
- Publication type:
- Article
Research progress in the role of absent in belanoma 2 in cancer pathogenesis and development.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 851, doi. 10.3872/j.issn.1007-385x.2022.09.011
- Publication type:
- Article
Immunocheckpoint inhibitor combined with endocrine therapy for simultaneous prostate cancer and lung squamous cell carcinoma:two case reports and literature reviews.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 856, doi. 10.3872/j.issn.1007-385x.2022.09.012
- Publication type:
- Article